Alcohol and porphyrin metabolism

Alcohol and Alcoholism

Volumn 35, Issue 2, 2000, Pages 109-125

  Doss, Manfred O ^a,b   Kühnel, Alexandra ^a   Gross, Ulrich ^a  

^a Fachbereich Medizin der Universitat Marburg   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINOLEVULINATE SYNTHASE; ALCOHOL; CHLOROQUINE; COMPLEMENTARY DNA; COPROPORPHYRIN; COPROPORPHYRINOGEN OXIDASE; FERROCHELATASE; GLUCOSE; HEME; PORPHOBILINOGEN DEAMINASE; PORPHOBILINOGEN SYNTHASE; PORPHYRIN; PORPHYRINOGEN; UROPORPHYRINOGEN DECARBOXYLASE;

ACUTE INTERMITTENT PORPHYRIA; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ALCOHOL METABOLISM; ARTICLE; CHRONIC DISEASE; CONGENITAL ERYTHROPOIETIC PORPHYRIA; DECARBOXYLATION; ENZYME ACTIVITY; ENZYME INDUCTION; GENE MUTATION; GENETIC DISORDER; HEME SYNTHESIS; HEPATIC PORPHYRIA; HUMAN; MOLECULAR BIOLOGY; NONHUMAN; PORPHYRIA; PORPHYRIA CUTANEA TARDA; PORPHYRIA VARIEGATA; PORPHYRIN METABOLISM; PRIORITY JOURNAL; URINARY EXCRETION;

ANIMALIA;

EID: 0343293967     PISSN: 07350414     EISSN: None     Source Type: Journal    
DOI: 10.1093/alcalc/35.2.109     Document Type: Article

References (158)

1. Abdulla, M., Haeger-Aronsen, B. and Sevensson, S. (1976) Effect of ethanol and zinc on ALA-dehydratase activity in red blood cells. Enzyme 21, 248-252.
2. Alkondon, M., Costa, A. C. S., Radhakrishnan, V., Aronstam, R. S. and Albuquerque, E. X. (1990) Selective blockade of NMDA activated channel currents may be implicated in learning deficits caused by lead. FEBS Letters 261, 124-130.
3. Altmann, L., Sveinsson, K. and Wiegand, H. (1991) Long-term potentiation in rat hippocampal slices is impaired following acute lead perfusion. Neuroscience Letters 128, 109-112.
4. Anderson, P. M. and Desnick, R. J. (1979) Purification and properties of δ-aminolevulinate dehydratase from human erythrocytes. Journal of Biological Chemistry 254, 6924-6930.
5. Aubin, H. J., Laureaux, C., Tilikete, S., Gillet, C., Lepetitcorps, A., Nguyen, T., Troupel, S., Paille, F. and Barrucand, D. (1997) How useful is aminolevulinic acid dehydratase as a marker of recent alcohol intake? Addiction Biology 2, 225-228.
6. Barton, J. C. and Conrad, M. E. (1978) Effects of ethanol on the absorption and retention of lead. Proceedings of the Society for Experimental Biology and Medicine 159, 213-218.
7. Beattie, D. S., Patton, G. M. and Rubin, E. (1973) The control of δ-aminolevulinic acid synthase in rat liver mitochondria. Effect of pyrazole on the apparent 'induction'. Enzyme 16, 252-257.
8. Bel, A. and Girard, D. (1980) Porphyrie cutanea tardive avec antigene HBs et hepatite chronique aggressive. Nouvelle Presse Medicale 9, 2027.
9. Blauvelt, A. (1996) Hepatitis C virus and human immunodeficiency virus infection can alter porphyrin metabolism and lead to porphyria cutanea tarda. Archives of Dermatology 132, 1503-1504.
10. Blauvelt, A., Harris, H. R., Hogan, D. J., Jimenez Acosta, F., Ponce, I. and Pardo, R. J. (1992) Porphyria cutanea tarda and human immunodeficiency virus infection. International Journal of Dermatology 31, 474-479.
11. Blitzer, R. D., Gil, O. and Landau, E. M. (1990) Long-term potentiation in rat hippocampus is inhibited by low concentrations of ethanol. Brain Research 537, 203-208.
12. Bloomer, J. R. (1976) The hepatic porphyrias. Pathogenesis, manifestations, and management. Gastroenterology 71, 689-701.
13. Bloomer, J. R. (1982) Protoporphyria. Seminars in Liver Disease 2, 143-153.
14. Bonkowsky, H. G. and Pomeroy, J. S. (1977) Human hepatic δ-aminolaevulinate synthase: requirement of an exogenous system for succinyl-co-enzyme A generation to demonstrate increased activity in cirrhotic and anticonvulsant-treated subjects. Clinical Science and Molecular Medicine 52, 509-521.
15. Bottomley, S. S., Tanaka, M. and Self, I. (1973) δ-aminolevulinic acid synthetase activity in normal human bone marrow and in patients with idiopathic sideroblastic anemia. Enzyme 16, 138-145.
16. Brodie, M. J., Thompson, G. C., Moore, M. R., McColl, K. E. L., Goldberg, A., Hardie, R. A. and Hunter, J. A. A. (1979) Haem biosynthesis in cutaneous hepatic porphyria: comparison with alcoholism and liver disease. Acta Hepatogastroenterologica 26, 122-128.
17. Brugsch, J. T. (1937) Toxic porphyrinuria following chronic alcoholism. Proceedings of the Staff Meetings of the Mayo Clinic 12, 609-613.
18. Calvert, G.M., Haring Sweeney, M., Fingerhut, M. A., Hornung, R. W. and Halperin, W. E. (1994) Evaluation of porphyria cutanea tarda in U.S. workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. American Journal of Industrial Medicine 25, 559-571.
19. Cederbaum, A. I. and Rubin, E. (1975) Molecular injury to mitochondria produced by ethanol and acetaldehyde. Federation Proceedings 34, 2045-2051.
20. Cox, T. C., Bawden, M. J., Martin, A. and May, B. K. (1991) Human erythroid 5-aminolevulinate synthase: Promotor analysis and identification of an iron-responsive element in the mRNA. EMBO Journal 10, 1891-1902.
21. Cribier, B., Petiau, P., Keller, F., Schmitt, C., Vetter, D., Heid, E. and Grosshaus, E. (1995) Porphyria cutanea tarda and hepatitis C viral infection. A clinical and virologic study. Archives of Dermatology 131, 801-804.
22. Cripps, D. J. (1987) Diet and alcohol effects on the manifestation of hepatic porphyrias. Federation Proceedings 46, 1894-1900.
23. Dandekar, T., Stripecke, R., Gray, N. K., Goossen, B., Constable, A., Johansson, H. E. and Hentze, M. W. (1991) Identification of a novel iron responsive element in murine and human erythroid 5-aminolevulinate acid synthase mRNA. EMBO Journal 10, 1903-1909.
24. Delfau-Larue, M. H., Martasek, P. and Grandchamp, B. (1994) Coproporphyrinogen oxidase: gene organization and description of a mutation leading to exon 6 skipping. Human Molecular Genetics 3, 1325-1330.
25. De Matteis, F. (1998) Porphyria cutanea tarda of the toxic and sporadic varieties. Clinics in Dermatology 16, 265-275.
26. Deybach, J. Ch, Puy, H., Robréau, A. M., Lamoril, J., da Silva, V., Grandchamp, B. and Nordmann, Y. (1996) Mutations in the protoporphyrinogen oxidase gene in patients with variegate porphyria. Human Molecular Genetics 5, 407-410.
27. Doss, M. (1980) Pathobiochemical transition of secondary coproporphyrinuria to chronic hepatic porphyria in humans. Klinische Wochenschrift 58, 141-148.
28. Doss, M. (1982) Hepatic porphyrias: Pathobiochemical, diagnostic, and therapeutic implications. In Progress in Liver Diseases, Popper, H. and Schaffner, F. eds, pp. 573-597. Grune & Stratton, New York.
29. Doss, M. O. (1985) Alcohol and porphyrin metabolism. In Alcohol Related Disease in Gastroenterology, Seitz, H. K. and Kommerell, B. eds, pp. 232-252. Springer, Berlin.
30. Doss, M. O. (1986) Lead intoxication as toxogenetic disease. Bollettino dell'Istituto Dermatologico S. Gallicano XIII, 115-122.
31. Doss, M. O. (1987) Porphyrinurias and occupational disease. Annals of the New York Academy of Sciences 514, 204-218.
32. Doss, M. O. (1990) Pathologie und Therapie der Porphyria cutanea tarda. Deutscher Dermatologe 38, 592-597.
33. Doss, M. O. and Gross, U. (1997) Hepatic porphyrias. In New Trends in Hepatology 1996, Gerok, W., Loginov, A. S. and Pokrowskij, V. I. eds, pp. 195-223. Kluwer, Dordrecht.
34. Doss, M. O. and Sassa, S. (1994) The porphyrias. In Laboratory Medicine. The Selection and Interpretation of Clinical Laboratory Studies, Noe, D. A. and Rock, R. C. eds, pp 535-553. Williams & Wilkins, Baltimore.
35. Doss, M. O. and Sieg, I. (1995) Alkohol und Porphyrinstoffwechsel. In Handbuch Alkohol, Alkoholismus, alkoholbedingte Organschäden, Seitz, H. K., Lieber, C. S. and Simanowski, U. A. eds, pp. 167-189. Johann Ambrosius Barth, Leipzig.
36. Doss, M. O., Nawrocki, P., Schmidt, A., Strohmeyer, G., Egbring, R., Schimpff, G., Dölle, W. and Korb, G. (1971) Einfluß von Diät, Glycin und Alkohol auf die Porphyrinurie bei chronischer hepatischer Porphyrie. Deutsche Medizinische Wochenschrift 96, 1229-1231.
37. Doss, M., Look, D., Henning, H., Nawrocki, P., Schmidt, A., Dölle, W., Korb, G., Lüders, C. J. and Strohmeyer, G. (1972) Hepatic porphyrins and urinary porphyrins and porphyrin precursors in liver cirrhosis. Klinische Wochenschrift 50, 1025-1032.
38. Doss, M., von Tiepermann, R., Stutz, G. and Teschke, R. (1980) Uroporphyrinogen decarboxylase inhibition in rat liver after alcohol ingestion. Medical Science 8, 562.
39. Doss, M., von Tiepermann, R., Stutz, G. and Teschke, R. (1981) Alcohol-induced decrease in uroporphyrinogen decarboxylase activity in rat liver and spleen. Enzyme 26, 24-31.
40. Doss, M. O., Baumann, H. and Sixel, F. (1982) Alcohol in acute porphyria. Lancet II, 1307.
41. Doss, M., Sauer, H., von Tiepermann, R. and Colombi, A. M. (1984) Development of chronic hepatic porphyria (porphyria cutanea tarda) with inherited uroporphyrinogen decarboxylase deficiency under exposure to dioxin. International Journal of Biochemistry 16, 369-373.
42. Doss, M., Sixel-Dietrich, F. and Verspohl, F. (1985) 'Glucose effect' and rate limiting function of uroporphyrinogen synthase on porphyrin metabolism in hepatocyte culture: relationship with human acute hepatic porphyrias. Journal of Clinical Chemistry and Clinical Biochemistry 23, 505-513.
43. Doss, M. O., Benkmann, H. G. and Goedde, H. W. (1986) δ-aminolevulinic acid dehydratase (porphobilinogen synthase) in two families with inherited enzyme deficiency. Clinical Genetics 30, 191-198.
44. Doss, M. O., Frank, M. and Braun-Falco, O. (1991) Porphyria cutanea tarda: erythrocyte decarboxylase activity in 471 consecutive patients. Current Problems in Dermatology 20, 97-105.
45. Doss, M. O., Honcamp, M. and Frank M. (1997) Arzneistoffe bei akuten hepatischen Porphyrien und Empfehlungen zur Anästhesie. In Rote Liste 1997, Cantor, E. ed, pp. 479-80. Aulendorf/Württ.
46. Doss, M. O., Gross, U., Lamoril, J., Kranl, C., Jacob, K., Doss, M., da Silva, V., Freesemann, A. G., Deybach, J-Ch., Sepp, N. and Nordmann, Y. (1999) Compound heterozygous hereditary copropotphyria with fluorescing teeth. Annals of Clinical Biochemistry 36, 680-682.
47. Drago, F., Battifoglio M. L., Gelati, G. and Rebora, A. (1995) Very low-dose chloroquine treatment for porphyria cutanea tarda. Acta Dermato-Venerelogica 75, 329-330.
48. Eales, L. (1979) Porphyria and the dangerous life-threatening drugs. South African Medical Journal 56, 914-917.
49. Elder, G. H. (1976) Acquired disorders of haem synthesis. Essays in Medical Biochemistry 2, 75-114.
50. Elder, G. H. (1998) Porphyria cutanea tarda. Seminars in Liver Disease 18, 67-76.
51. Elder, G. H. and Nordmann, Y. (1990) The molecular biology of porphyrias. In A Century of Porphyria, Vol. 11, Moore, M. R. ed., pp. 125-133. Pergamon Press, London.
52. Elder, G. H., Evans, J. O. and Matlin, S. A. (1976) The effect of the porphyrinogenic compound, hexachlorobenzene, on the activity of hepatic uroporphyrinogen decarboxylase in the rat. Clinical Science and Molecular Medicine 51, 71-80.
53. Fargion, S., Piperno, A., Cappellini, M. D., Sampietro, M. and Fracanzani, A.L. (1992) Hepatitis C virus and porphyria cutanea tarda: Evidence of a strong association. Hepatology 16, 1322-1326.
54. Ferri, C., Baicchi, U., La Civita, L., Greco, F., Longombardo, G. and Mazzoni, A. (1993) Hepatitis C virus-related autoimmunity in patients with porphyria cutanea tarda. European Journal of Clinical Investigation 23, 851-855.
55. Franke, K. and Fikentscher, R. (1935) Die Bedeutung der quantitativen Porphyrinbestimmung mit der Lumineszenzmessung für die Prüfung der Leberfunktion und für Ernährungsfragen. Münchener Medizinische Wochenschrift 82, 171-172.
56. Fraser, M. B. and Schacter, B. A. (1980) Increased bone marrow delta-aminolevulinic acid synthetase activity in the acute reversible sideroblastic anemia of alcoholics. American Journal of Hematology 8, 149-156.
57. Freesemann, A., Frank, M., Sieg, I. and Doss, M. O. (1995) Treatment of porphyria cutanea tarda by the effect of chloroquine on the liver. Skin Pharmacology 8, 156-161.
58. Freesemann, A. G., Gross, U., Bensidhoum, M., de Verneuil, H. and Doss, M. O. (1998) Immunological, enzymatic and biochemical studies of uroporphyrinogen III-synthase deficiency in 20 patients with congenital erythropoietic porphyria. European Journal of Biochemistry 257, 149-153.
59. Fujita, H., Koizumi, A., Furusawa, T. and Ikeda, M. (1987) Decreased erythrocyte δ-aminolevulinate dehydratase activity after styrene exposure. Biochemical Pharmacology 36, 711-716.
60. Fujita, H., Kondo, M., Taketani, S., Nomura, N., Furuyama, K., Akagi, R., Nagai, T., Terajima, M., Galbraith, R. A. and Sassa, S. (1994) Characterization and expression of cDNA encoding coproporphyrinogen oxidase from a patient with hereditary coproporphyria. Human Molecular Genetics 3, 1807-1810.
61. Garey, J. R., Franklin, K. F., Brown, D. A., Harrison, L. M., Metcalf, K. M. and Kushner, J. P. (1993) Analysis of uroporphyrinogen decarboxylase complementary DNAs in sporadic porphyria cutanea tarda. Gastroenterology 105, 165-169.
62. Garey, R., Harrison, L. M., Franklin, K. F., Metcalf, K. M., Radisky, E. S. and Kushner, J. P. (1990) Uroporphyrinogen decarboxylase: a splice site mutation causes the deletion of exon 6 in multiple families with porphyria cutanea tarda. Journal of Clinical Investigation 86, 1416-1422.
63. Goldberg, A. and Rimington, C. (1962) Diseases of porphyrin metabolism, pp. 19-20. Thomas, Springfield.
64. Goldberg, A., McColl, K. E. L. and Moore, M. R. (1981) Alcohol and porphyria. Lancet II, 905-906.
65. Gouya, L., Deybach, J. Ch., Lamoril, J., da Silva, V., Beaumont, C., Grandchamp, B. and Nordmann, Y. (1996) Modulation of the phenotype in dominant erythropoietic protoporphyria by a low expression of the normal ferrochelatase allele. American Journal of Human Genetics 58, 292-299.
66. Gouya, L., Puy, H., Lamoril, J., Da Silva, V., Grandchamp, B., Nordmann, Y. and Deybach, J.-C. (1999) Inheritance in erythropoietic protoporphyria: a common wild-type ferrochelatase allelic variant with low expression accounts for clinical manifestation. Blood 93, 2105-2110.
67. Grandchamp, B., Lamoril, J. and Puy, H. (1995) Molecular abnormalities of coproporphyrinogen oxidase in patients with hereditary coproporphyria. Journal of Bioenergetics and Biomembranes 27, 215-219.
68. Grossmann, M. E., Bickers, D. R., Poh-Fitzpatrick, M. B., Deleo, V. A. and Harber, L. C. (1979) Porphyria cutanea tarda. Clinical features and laboratory findings in 40 patients. American Journal of Medicine 67, 277-286.
69. Groß, U., Honcamp, M., Daume, E., Frank, M., Düsterberg, B. and Doss, M. O. (1995) Hormonal oral contraceptives, urinary porphyrin excretion and porphyrias. Hormone and Metabolic Research 27, 379-383.
70. Groß, U., Honcamp, M. and Doss, M. O. (1996) Heterogeneity of AIP: a subtype with normal PBG deaminase activity in erythrocytes in Germany. European Journal of Clinical Chemistry and Clinical Biochemistry 34, 613-618.
71. Groß, U., Sassa, S., Jacob, K., Deybach, J-C., Nordmann, Y., Frank, M. and Doss, M. O. (1998) 5-aminolevulinic acid dehydratase deficiency porphyria: a twenty-year clinical and biochemical followup. Clinical Chemistry 44, 1892-1896.
72. Grover, C. A., Frye, G. D. and Griffith, W. H. (1994) Acute tolerance to ethanol inhibition of NMDA-mediated EPSPs in CA1 region of the rat hippocampus. Brain Research 642, 70-76.
73. Grover, C. A., Jasek, M. C., Frye, G. D. and Griffith, W. H. (1997) Ethanol inhibition of reduced frequency-dependent rundown of calcium currents in acutely dissociated MS/nDB neurons from chronic in vivo lead-exposed adult rats. Neurotoxicology 18, 179-190.
74. Habermann, H. F., Rosenberg, F. and Menon, I. A. (1975) Porphyria cutanea tarda: comparison of cases precipitated by alcohol and estrogens. Canadian Medical Association Journal 113, 653-655.
75. Hahn, M. and Bonkovsky, H. L. (1997) Multiple chemical sensitivity syndrome and porphyria. Archives of Internal Medicine 157, 281-285.
76. Hamlyn, A. N., Hopper, J. C. and Skillen, A. W. (1979) Assessment of erythrocyte δ-aminolevulinate dehydratase for outpatient detection of alcoholic liver disease: comparison with γ-glutamyltransferase and casual blood ethanol. Clinica Chimica Acta 95, 453-459.
77. Harigae, H., Suwabe, N., Weinstock, P. H., Nagai, M., Fujita, H., Yamamoto, M. and Sassa, S. (1998) Deficient heme and globin synthesis in embryonic stem cells lacking the erythroid-specific δ-aminolevulinate synthase gene. Blood 91, 798-805.
78. Held, H. (1977) Effect of alcohol on the heme and porphyrin synthesis interaction with phenobarbital and pyrazole. Digestion 15, 136-146.
79. Held, J. L., Sassa, S., Kappas, A. and Harber, L. C. (1989) Erythrocyte uroporphyrinogen decarboxylase activity in porphyria cutanea tarda: a study of 40 consecutive patients. Journal of Investigative Dermatology 93, 332-334.
80. Henriksson, M., Timonen, K., Mustajoki, P., Pihlaja, H., Tenhunen, R., Peltonen, L. and Kauppinen, R. (1996) Four novel mutations in the ferrochelatase gene among erythropoietic protoporphyria patients. Journal of Investigative Dermatology 106, 346-350.
81. Hift, R. and Kirsch, R. E. (1995) Porphyria cutanea tarda. In Alcoholic Liver Disease, Hall, P. ed., pp. 219-228. Edward Arnold, London.
82. Hindmarsh, J. T. (1998) Enzyme assays and the porphyrias: which tissues and when indicated. Clinical Dermatology 16, 245-250.
83. Ishida, N., Fujita, H., Fukuda, Y., Noguchi, T., Doss, M., Kappas, A. and Sassa, S. (1992) Cloning and expression of the defective genes from a patient with δ-aminolevulinate dehydratase porphyria. Journal of Clinical Investigation 89, 1431-1437.
84. Jones, R. E. and Chelsky, M. (1986) Further discussion concerning porphyria cutanea tarda and TCDD exposure. Archives of Environmental Health 41, 100-103.
85. Kalow, W. (1962) Pharmacogenetics. Heredity and the Response to Drugs. Saunders, Philadelphia.
86. Kaplowitz, N., Javitt, N. and Kappas, A. (1972) Coproporphyrin I and III excretion in bile and urine. Journal of Clinical Investigation 51, 2895-2899.
87. Kappas, A., Sassa, S., Galbraith, A. and Nordmann, Y. (1995) The porphyrias. In The Metabolic and Molecular Bases of Inherited Disease, Scriver, C. R., Beaudet, A. L., Sly, W. S. and Vale, D. eds, pp. 2103-2159. McGraw-Hill, New York.
88. Kaupinen, R., Timonen, K. and Mustajoki, P. (1994) Treatment of the porphyrias. Annals of Medicine 26, 31-38.
89. Keithly, J. H. and Nudler, K. D. (1983) Protoporphyrin formation in Rhizobium japonicum. Journal of Bacteriology 154, 838-845.
90. Kodama, T., Kondo, M., Urata, G., Satoh, H., Ohtake, H., Iwasaki, Y., Itakura, H., Ohkubo, A. and Kosaka, K. (1983) Changes in aminolevulinate synthase and aminolevulinate dehydratase activity in cirrhotic liver. Gastroenterology 84, 236-241.
91. Kondo, M., Urata, G. and Shimizu, Y. (1983) Decreased liver δ-aminolaevulinate dehydratase activity in porphyria cutanea tarda and in alcoholism. Clinical Science 65, 423-428.
92. Köstler, E. and Doss, M. O. (1993) Porphyria cutanea tarda (chronische hepatische Porphyrie). In Ergebnisse der inneren Medizin und Kinderheilkunde, Vol. 61, pp. 124-170. Springer-Verlag, Berlin.
93. Koszo, F., Horvath, L. I., Simon, N., Siklosi, C. S. and Kiss, M. (1982) The role of possible membrane damage in porphyria cutanea tarda: a spin label study of rat liver cell membranes. Biochemical Pharmacology 31, 11-17.
94. Krasner, N., Moore, M. R., Thompson, G. G., McIntosh, W. and Goldberg, A. (1974) Depression of erythrocyte δ-aminolaevulinate acid dehydratase activity in alcoholics. Clinical Science and Molecular Medicine 46, 415-418.
95. Labbe, R. F. and Nielsen, L. (1976) Clinical-biochemical interpretations of erythrocyte protoporphyrin. Ferrochelatase-pyridoxal phosphate studies. In Porphyrins in Human Diseases, Doss, M. ed., pp. 141-147. Karger, Basel.
96. Labbe, R. F., Nutter, J., Cowger, M. L. and Nielsen, L. D. (1970) Control of heme biosynthesis. Effect of nicotinamide adenine dinucleotide on the induction of delta-aminolaevulinic acid synthase. Biochemical Medicine 3, 465-474.
97. Lacour, J. P., Bodokh, I., Castanet, J., Bekri, S. and Ortonne, J. P. (1993) Porphyria cutanea tarda and antibodies to hepatitis C virus. British Journal of Dermatology 128, 121-123.
98. Lamoril, J., Martasek, P., Deybach, J.-C., da Silva, V., Grandchamp, B. and Nordmann, Y. A. (1995) Molecular defect in coproporphyrinogen oxidase gene causing harderoporphyria, a variant form of hereditary coproporphyria. Human Molecular Genetics 4, 275-278.
99. Lamoril, J., Deybach, J. C., Puy, H., Grandchamp, B. and Nordmann, Y. (1997) Three novel mutations in the coproporphyrinogen oxidase gene. Human Mutation 9, 78-80.
100. Lane, S. E. and Stewart, M. E. (1983) Alcohol-mediated effects on the level of cytochrome P-450 and heme biosynthesis in cultured rat hepatocytes. Biochimica et Biophysica Acta 755, 313-317.
101. Lefkowitch, J. H. and Grossmann, M. E. (1983) Hepatic pathology in porphyria cutanea tarda. Liver 3, 19-29.
102. Li, F., Lim, C. K., Simpson, K. J. and Peters, T. J. (1989) Coproporphyrinogen oxidase, protoporphyrinogen oxidase and ferrochelatase activities in human liver biopsies with special reference to alcoholic liver disease. Journal of Hepatology 8, 86-93.
103. Li, F., Lim, C. K. and Peters, T. J. (1990) Coproporphyrinogen oxidase, protoporphyrinogen oxidase and ferrochelatase activities in iron-overloaded and ethanol-treated rats. Biomedical Chromatography 4, 253-256.
104. Lieber, C. S. (1980) Metabolism and metabolic effects of alcohol. Seminars in Hematology 17, 85-99.
105. Lindberg, R. L. P., Porcher, C., Grandchamp, B., Ledermann, B., Bürki, K., Brandner, S., Aguzzi, A. and Meyer, U. A. (1996) Porphobilinogen deaminase deficiency in mice causes neuropathy resembling that of human hepatic porphyria. Nature Genetics 12, 195-199.
106. Lobato, M. N. and Berger, T. G. (1988) Porphyria cutanea tarda associated with the acquired immunodeficiency syndrome. Archives of Dermatology 124, 1009-1010.
107. Martasek, P., Nordmann, Y. and Grandchamp, B. (1994) Homozygous hereditary coproporphyria caused by an arginine to tryptophane substitution in coproporphyrinogen oxidase and common intragenic polymorphisms. Human Molecular Genetics 3, 477-480.
108. Martinez, M.-V. R., Espinosa Aguilar, M. D., Sanchez-Vizcaino, J., Quintero Fuentes, D., Nogueras Lopez, F. and Lopez de Hierro Rinz, M. (1996) Association entre porfiria cutanea tarda y virus de la hepatitis C. Revista Espanola de Enfermedades Digestivas 88, 231-236.
109. Mazurier, F., Moreau-Gaudry, F., Salesse, S., Barbot, C., Ged, C., Reiffers, J. and de Verneuil, H. (1997) Gene transfer of the uroporphyrinogen III synthase cDNA into haematopoietic progenitor cells in view of a future gene therapy in congenital erythropoietic porphyria. Journal of Inherited Metabolic Disease 20, 247-257.
110. McColl, K. E. L., Thompson, G. G., Moore, M. R. and Goldberg, A. (1980) Acute ethanol ingestion and haem biosynthesis in healthy subjects. European Journal of Clinical Investigation 10, 107-112.
111. McColl, K. E. L., Moore, M. R., Thompson, G. G. and Goldberg, A. (1981) Abnormal haem biosynthesis in chronic alcoholics. European Journal of Clinical Investigation 11, 461-468.
112. McEwin, R. (1976) Porphyria in Australia. In Porphyrins in Human Diseases, Doss, M. ed., pp. 233-244. Karger, Basel.
113. Mezey, E. (1976) Ethanol metabolism and ethanol-drug interactions. Biochemical Pharmacology 25, 869-875.
114. Moore, M. R. (1974) The effects of ethanol on haem biosynthesis. In Proceedings of the First International Symposium on Alcohol and Aldehyde Metabolizing Systems, Thurman, R. G. ed., p. 543. Academic Press, London.
115. Moore, M. R. (1980) International review of drugs in acute porphyria - 1980. International Journal of Biochemistry 12, 1089-1097.
116. Moore, M. R. (1998) The biochemistry of heme synthesis in porphyria and in the porphyrinurias. Clinics in Dermatology 16, 203-223.
117. Moore, M. R., Beattie, A. D., Thompson, G. G. and Goldberg, A. (1971) Depression of δ-aminolaevulinic acid dehydratase activity by ethanol in man and rat. Clinical Science 40, 81-88.
118. Moore, M. R., McColl, K. E. and Goldberg, A. (1984) The effects of alcohol on porphyrin biosynthesis and metabolism. Contemporary Issues in Clinical Biochemistry 1, 161-187.
119. Moran-Jimenez, M. J., Ged, C., Romana, M., de Salamanca, E., Taïeb, A., Topi, G., D'Alessandro, L. and de Verneuil, H. (1996) Uroporphyrinogen Decarboxylase: complete human gene sequence and molecular study of three families with hepatoerythropoietic porphyria. American Journal of Human Genetics 58, 712-721.
120. Mukerji, S. K., Pimstone, N. R. and Burns, M. (1984) Dual mechanism of inhibition of rat liver uroporphyrinogen decarboxylase activity by ferrous iron: its potential role in the genesis of porphyria cutanea tarda. Gastroenterology 87, 1248-1254.
121. Mukerji, S. K., Saicheur, T. and Pimstone, N. R. (1997) Alcohol metabolism in liver disease may trigger clinical porphyria cutanea tarda because iron released from ferritin inhibits uroporphyrinogen decarboxylase activity and induces hepatic lipid peroxidation. Acta Haematologica 98, 452.
122. Mustajoki, P. and Nordmann, Y. (1993) Early administration of heme arginate for acute porphyric attacks. Archives of Internal Medicine 153, 2004-2008.
123. Mustajoki, P., Kauppinen, R., Lannfelt, L. and Koistinen, J. (1992) Frequency of low PBG deaminase activity in Finland. Journal of Internal Medicine 231, 389-395.
124. Navas, S., Bosch, O., Castillo, I., Marriott, E. and Carreno, V. (1995) Porphyria cutanea tarda and hepatitis C and B viruses infection: a retrospective study. Hepatology 21, 279-284.
125. Nordmann, Y. (1991) Human hereditary porphyrias. In Oxford Textbook of Clinical Hepatology, McIntyre, N., Benhamou, J.-P., Bircher, J., Rizzetto, M. and Rodes, J. eds, pp. 974-985. Oxford University Press, Oxford.
126. Nordmann, Y., de Verneuil, H., Deybach, J.-C., Delfau, M. H. and Grandchamp, B. (1990) Molecular genetics of porphyrias. Annals of Medicine 22, 387-391.
127. Orten, J. M., Doehr, S. A., Bond, C., Johnson, H. and Pappas, A. (1963) Urinary excretion of porphyrins and porphyrin intermediates in human alcoholics. Quarterly Journal of Studies on Alcohol 24, 598-609.
128. Ostrowski, J., Kosecki, P., Martynska, M. and Milewski, B. (1984) Urinary porphyrins in liver disease. Scandinavian Journal of Gastroenterology 19, 862-866.
129. Pennington, S. N., Smith, C. P. and Tapseott, E. B. (1978) Effect of an acute dose of ethanol on rat liver microsomal mixed function oxygenase components and membrane lipid composition. Alcoholism: Clinical and Experimental Research 2, 311-316.
130. Polo, C. F., Afonso, S. G., Navone, N. M., Rossetti, M. V. and Del C Batlle, A. M. (1995) Zinc aminolevulinic acid dehydratase reactivation index as a tool for diagnosis of lead exposure. Ecotoxicology and Environmental Safety 32, 267-272.
131. Puy, H., Robréau, A. M., Rosipal, R., Nordmann, Y. and Deybach, J. Ch. (1996) Protoporphyrinogen oxidase: complete genomic sequence and polymorphisms in the human gene. Biochemical and Biophysical Research Communications 226, 226-230.
132. Puy, H., Deybach, J. C., Lamoril, J., Robreau, A. M., da Silva, V., Gouya, L., Grandchamp, B. and Nordmann, Y. (1997) Molecular epidemiology and diagnosis of PBG deaminase gene defects in acute intermittent porphyria. American Journal of Human Genetics 60, 1373-1383.
133. Quecedo, L., Costa, J. and Enriquez de Salamanca, R. (1996) Papel del virus de la hepatitis C en la hepatopatia de la porfiria cutanea tarda. Medicina Clinica 106, 321-324.
134. Rubin, E. and Lieber, C. S. (1972) Alcoholism, alcohol, and drugs. Science 172, 1097-1102.
135. Salmon, P. (1996) Hepatitis C virus infection and porphyria cutanea tarda in Australasia. Archives of Dermatology 132, 191.
136. Sarkany, R. P. E. and Cox, T. M. (1995) Autosomal recessive erythropoietic protoporphyria: a syndrome of severe photosensitivity and liver failure. Quarterly Journal of Medicine 88, 541-549.
137. Sarkany, R. P. E., Alexander, G. J. M. A. and Cox, T. M. (1994) Recessive inheritance of erythropoietic protoporphyria with liver failure. Lancet 343, 1394-1396.
138. Schoenfeld, N., Mamet, R., Dotan, I., Sztern, M., Levo, Y. and Aderka, D. (1995) Relation between uroporphyrin excretion, acute attacks of hereditary coproporphyria and successful treatment with haem arginate. Clinical Science 88, 365-369.
139. Schoenfeld, N., Mamet, R., Leibovici, L. and Lanir, A. (1996) Alcohol-induced changes in urinary aminolevulinic acid and porphyrins: Unrelated to liver disease. Alcohol 13, 59-63.
140. Schreiber, W. E., Zhang, X., Senz, J. and Jamani, A. (1997) Hereditary coproporphyria: Exon screening by heteroduplex analysis detects three novel mutations in the coproporphyrinogen oxidase gene. Human Mutation 10, 196-200.
141. Shanley, B. C., Zail, S. S. and Joubert, S. M. (1968) Effect of ethanol on liver δ aminolevulinate synthetase in rats. Lancet II, 70-71.
142. Shanley, B. C., Zail, S. S. and Joubert, S. M. (1969) Effect of ethanol on liver δ-aminolevulinate synthase activity and urinary porphyrin excretion in symptomatic porphyria. British Journal of Haematology 17, 389-396.
143. Shemin, D. (1976) 5-Aminolaevulinic acid dehydratase: structure, function, and mechanism. Philosophical Transactions of the Royal Society of London Series B - Biological Science 273, 109-115.
144. Sieg, I., Doss, M. O., Kandels, H. and Schneider, J. (1991) Effect of alcohol on δ-aminolevulinic acid dehydratase and porphyrin metabolism in man. Clinica Chimica Acta 202, 211-218.
145. Soriano, E., Catala, M. T., Lacruz, J., Campayo, A., Lopez Aldeguer, J. and Perello, A. (1993) Porphyria cutanea tarda y infeccion por el virus de la immunodeficiencia humana. Revista Clinica Espanola 192, 120-122.
146. Stölzel, U., Köstler, E., Koszka, C., Stöffler-Meilicke, M., Schuppan, D., Somasundaram, R., Doss, M. O., Habermehl, K. O. and Riecken, E. O. (1995) Low prevalence of hepatitis C virus infection in porphyria cutanea tarda in Germany. Hepatology 21, 1500-1503.
147. Strik, J. J. T. W. A. and Doss, M. (1978) Chronisch hepatische Porphyrie durch polyhalogenisierte aromatische Verbindungen bei Menschen. Therapiewoche 28, 8460-8466.
148. Susa, S., Daimon, M., Yamamori, I., Kondo, M., Yamatani, K., Sasaki, H. and Kato, T. (1998) A novel mutation of coproporphyrinogen oxidase (CPO) gene in a Japanese family. Journal of Human Genetics 43, 182-184.
149. Sutherland, D. A. and Watson, C. J. (1951) Studies on coproporphyrin. VI. The effect of alcohol on the per diem excretion and isomer distribution of the urinary coproporphyrins. Journal of Laboratory and Clinical Medicine 37, 29-39.
150. Teschke, R., Bolsen, K., Landmann, H. and Goertz, G. (1983) Effect of hexachlorobenzene on the activities of hepatic alcohol metabolizing enzymes. Biochemical Pharmacology 32, 1745-1751.
151. Teschke, R., Gorys-Könemann, C., Daldrup, T. and Goerz, G. (1987) Influence of chronic alcohol consumption on hepatic heme and porphyrin metabolism. Biochemical Pharmacology 36, 1133-1138.
152. Thunell, S., Floderus, Y., Henrichson, A., Moore, M. R., Meissner, P. and Sinclair, J. (1992) Alcoholic beverages in acute porphyria. Journal of Studies on Alcohol 3, 272-276.
153. Topi, G. C., Amantea, A. and Griso, D. (1984) Recovery from porphyria cutanea tarda with no specific therapy other than avoidance of hepatic toxins. British Journal of Dermatology 111, 75-82.
154. Von Tiepermann, R., Koss, G. and Doss, M. (1980) Uroporphyrinogen decarboxylase deficiency in experimental chronic hepatic porphyria. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 361, 1217-1222.
155. Warnich, L., Kotze, M. J., Groenewald, I. M., Groenewald, J. Z., van Brakel, M. G., van Heerden, C. J., de Villiers, J. N. P., van de Ven, W. J. M., Schoenemakers, E. F. P. M., Taketani, S. and Retief, A. E. (1996) Identification of three mutations and associated haplotypes in the protoporphyrinogen oxidase gene in South African families with variegate porphyria. Human Molecular Genetics 5, 981-984.
156. Wetterberg, L. (1976) Report on an international survey of safe and unsafe drugs in acute intermittent porphyria. In Porphyrins in Human Diseases - Report of the Discussions, Doss, M. and Nawrocki, P. eds, pp. 191-202. Falk Foundation, Freiburg.
157. Wissel, P. S., Sordillo, P., Anderson, K. E., Sassa, S., Savillo, R. L. and Kappas, A. (1987) Porphyria cutanea tarda associated with the acquired immune deficiency syndrome. American Journal of Dermatology 25, 107-113.
158. Wright, D. J., Lim, C. K. and Peters, T. J. (1990) High performance liquid chromatographic studies of erythrocyte haem biosynthetic enzyme activities in alcoholic macrocytosis. Biomedical Chromatography 4, 249-252.